Standard
Validation of Alternative Left Atrial Indexation Methods in Obesity. / Olsen, Flemming Javier; Biering-Sørensen, Tor.
I:
Journal of the American Society of Echocardiography, Bind 35, Nr. 11, 2022, s. 1184-1185.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Olsen, FJ
& Biering-Sørensen, T 2022, '
Validation of Alternative Left Atrial Indexation Methods in Obesity',
Journal of the American Society of Echocardiography, bind 35, nr. 11, s. 1184-1185.
https://doi.org/10.1016/j.echo.2022.05.014APA
Olsen, F. J.
, & Biering-Sørensen, T. (2022).
Validation of Alternative Left Atrial Indexation Methods in Obesity.
Journal of the American Society of Echocardiography,
35(11), 1184-1185.
https://doi.org/10.1016/j.echo.2022.05.014Vancouver
Olsen FJ
, Biering-Sørensen T.
Validation of Alternative Left Atrial Indexation Methods in Obesity.
Journal of the American Society of Echocardiography. 2022;35(11):1184-1185.
https://doi.org/10.1016/j.echo.2022.05.014Author
Olsen, Flemming Javier ; Biering-Sørensen, Tor. / Validation of Alternative Left Atrial Indexation Methods in Obesity. I: Journal of the American Society of Echocardiography. 2022 ; Bind 35, Nr. 11. s. 1184-1185.
Bibtex
@article{6adf472dbc994843afe25766893c4f35,
title = "Validation of Alternative Left Atrial Indexation Methods in Obesity",
author = "Olsen, {Flemming Javier} and Tor Biering-S{\o}rensen",
note = "Funding Information: The Copenhagen City Heart Study was funded by the Danish Heart Foundation. The echocardiographic substudy was funded by the Lundbeck Foundation. F.J.O. was funded by grants from the Danish Heart Foundation (no. 18-R125-A8534-22083), Fru Asta Florida Boldings Mindelegat, Kong Christian den Tiendes fond, and Copenhagen University Hospital—Herlev and Gentofte Hospital. T.B.-S. was supported by the Fondb{\o}rsvekselerer Henry Hansen og Hustrus Hovedlegat, the Lundbeck Foundation, and the Novo Nordisk Foundation. The funding organizations did not have any involvement in study design, conduct, or manuscript preparation. Conflicts of Interest: T.B.-S. is a Steering Committee member of the Amgen-financed GALACTIC-HF trial and the Boston Scientific–financed LUX-Dx TRENDS trial; is on the Advisory Board of Sanofi Pasteur and Amgen; received a speaker honorarium from Novartis and Sanofi Pasteur; and received research grants from GE Healthcare and Sanofi Pasteur. None of these organizations had any involvement in the study. Funding Information: The Copenhagen City Heart Study was funded by the Danish Heart Foundation . The echocardiographic substudy was funded by the Lundbeck Foundation . F.J.O. was funded by grants from the Danish Heart Foundation (no. 18-R125-A8534-22083 ), Fru Asta Florida Boldings Mindelegat , Kong Christian den Tiendes fond , and Copenhagen University Hospital — Herlev and Gentofte Hospital . T.B.-S. was supported by the Fondb{\o}rsvekselerer Henry Hansen og Hustrus Hovedlegat , the Lundbeck Foundation , and the Novo Nordisk Foundation . The funding organizations did not have any involvement in study design, conduct, or manuscript preparation. ",
year = "2022",
doi = "10.1016/j.echo.2022.05.014",
language = "English",
volume = "35",
pages = "1184--1185",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Elsevier",
number = "11",
}
RIS
TY - JOUR
T1 - Validation of Alternative Left Atrial Indexation Methods in Obesity
AU - Olsen, Flemming Javier
AU - Biering-Sørensen, Tor
N1 - Funding Information:
The Copenhagen City Heart Study was funded by the Danish Heart Foundation. The echocardiographic substudy was funded by the Lundbeck Foundation. F.J.O. was funded by grants from the Danish Heart Foundation (no. 18-R125-A8534-22083), Fru Asta Florida Boldings Mindelegat, Kong Christian den Tiendes fond, and Copenhagen University Hospital—Herlev and Gentofte Hospital. T.B.-S. was supported by the Fondbørsvekselerer Henry Hansen og Hustrus Hovedlegat, the Lundbeck Foundation, and the Novo Nordisk Foundation. The funding organizations did not have any involvement in study design, conduct, or manuscript preparation. Conflicts of Interest: T.B.-S. is a Steering Committee member of the Amgen-financed GALACTIC-HF trial and the Boston Scientific–financed LUX-Dx TRENDS trial; is on the Advisory Board of Sanofi Pasteur and Amgen; received a speaker honorarium from Novartis and Sanofi Pasteur; and received research grants from GE Healthcare and Sanofi Pasteur. None of these organizations had any involvement in the study.
Funding Information:
The Copenhagen City Heart Study was funded by the Danish Heart Foundation . The echocardiographic substudy was funded by the Lundbeck Foundation . F.J.O. was funded by grants from the Danish Heart Foundation (no. 18-R125-A8534-22083 ), Fru Asta Florida Boldings Mindelegat , Kong Christian den Tiendes fond , and Copenhagen University Hospital — Herlev and Gentofte Hospital . T.B.-S. was supported by the Fondbørsvekselerer Henry Hansen og Hustrus Hovedlegat , the Lundbeck Foundation , and the Novo Nordisk Foundation . The funding organizations did not have any involvement in study design, conduct, or manuscript preparation.
PY - 2022
Y1 - 2022
U2 - 10.1016/j.echo.2022.05.014
DO - 10.1016/j.echo.2022.05.014
M3 - Letter
C2 - 35688306
AN - SCOPUS:85133344276
VL - 35
SP - 1184
EP - 1185
JO - Journal of the American Society of Echocardiography
JF - Journal of the American Society of Echocardiography
SN - 0894-7317
IS - 11
ER -
